What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Search narrowed by
Havrix and associated names New
Referral
|
02/09/2024
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Methylprednisolone (systemic formulations) New
PSUR-outcome
|
02/09/2024
Further information and amendments to the product information can be found on the EMA website.
Mpox assessment New
Safety warnings
|
Blood & Tissue
|
02/09/2024
The Federal Office for Safety in Health Care would like to draw your attention to the current assessment of the ECDC (European Center for Disease Prevention and Control) on Mpox.
Safety warnings
|
Blood & Tissue
|
02/09/2024
The Federal Office for Safety in Health Care has been informed by the ECDC (European Center for Disease Prevention and Control) that human WNV infections have been recorded in Bulgaria, in Sofia.
Safety warnings
|
Blood & Tissue
|
02/09/2024
The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that in Greece, in addition to the regions already announced, in Ileia, Voiotia, Thasos, Kavala, Aitoloakarnania and Anatoliki Attiki, confirmed human WNV-infections have been recorded.
Hydroxycarbamide New
PSUR-outcome
|
30/08/2024
Further information and amendments to the product information can be found on the EMA website.
Recall
|
21/08/2024
Clinical investigations with medical devices Regulation on electronic submission Electronic Submission Form of the BASG General requirements for applications (technical validation) Clinical investigat
Atorvastatin New
PSUR-outcome
|
19/08/2024
Further information and amendments to the product information can be found on the EMA website.
Bumetanide New
PRAC signal recommendation
|
14/08/2024
Risko for toxic epidermal necrolysis and Stevens-Johnson syndrome. Further information and amendments to the product information can be found on the EMA website.
Acetazolamide New
PRAC signal recommendation
|
14/08/2024
Pulmonary oedemas. Further information and amendments to the product information can be found on the EMA website.